Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

Autor: Sands, Bruce E., Chen, Jingjing, Feagan, Brian G., Penney, Mark, Rees, William A., Danese, Silvio, Higgins, Peter D.R., Newbold, Paul, Faggioni, Raffaella, Patra, Kaushik, Li, Jing, Klekotka, Paul, Morehouse, Chris, Pulkstenis, Erik, Drappa, Jörn, van der Merwe, René, Gasser, Robert A., Jr.
Zdroj: In Gastroenterology July 2017 153(1):77-86
Databáze: ScienceDirect